The global peripheral angiography equipment market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing number of patients with cardiovascular diseases and rising demand for minimally invasive procedures.
The magnetic resonance imaging segment accounted for the largest share in 2017, followed by computed tomography and ultrasound segments. Magnetic resonance imaging segment is expected to maintain its dominance throughout the forecast period due to its high accuracy in diagnosing vascular diseases such as aneurysms, arteriovenous malformations, and venous thrombosis.
Some Of The Growth Factors Of This Market:
- The increasing number of patients with peripheral vascular disease is expected to drive the growth of the peripheral angiography equipment market.
- The increasing prevalence of diabetes and obesity is also expected to fuel the growth of this market, as these conditions are associated with an increased risk for peripheral vascular disease.
- The introduction of new technologies in this field is also expected to fuel the growth of this market, as it will help improve diagnosis and treatment options for patients suffering from peripheral vascular disease.
- Increasing awareness about peripheral vascular diseases among physicians and patients will also drive the growth of this market.
- Increasing government funding for research on peripheral vascular diseases will also fuel the growth of this market.
Industry Growth Insights published a new data on “Peripheral Angiography Equipment Market”. The research report is titled “Peripheral Angiography Equipment Market research by Types (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Nuclear Imaging, X-ray), By Applications (Hospitals, Diagnostic Imaging Centres, Others), By Players/Companies Siemens Healthineers (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Samsung Medison (South Korea), Shimadzu Corp. (Japan), St. Jude Medical, Inc. (U.S.), TERUMO Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Fujifilm SonoSite (Japan), Hologic, Inc. (U.S.), Esaote SpA (Italy), Carestream Health, Inc. (U.S.), Konica Minolta (Japan), Alpinion Medical Systems (South Korea)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Peripheral Angiography Equipment Market Research Report
By Type
Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Nuclear Imaging, X-ray
By Application
Hospitals, Diagnostic Imaging Centres, Others
By Companies
Siemens Healthineers (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Samsung Medison (South Korea), Shimadzu Corp. (Japan), St. Jude Medical, Inc. (U.S.), TERUMO Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Fujifilm SonoSite (Japan), Hologic, Inc. (U.S.), Esaote SpA (Italy), Carestream Health, Inc. (U.S.), Konica Minolta (Japan), Alpinion Medical Systems (South Korea)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Peripheral Angiography Equipment Market Report Segments:
The global Peripheral Angiography Equipment market is segmented on the basis of:
Types
Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Nuclear Imaging, X-ray
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Imaging Centres, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens Healthineers (Germany)
- GE Healthcare (U.K.)
- Toshiba Medical Systems Corporation (Japan)
- Hitachi Medical Corporation (Japan)
- Samsung Medison (South Korea)
- Shimadzu Corp. (Japan)
- St. Jude Medical, Inc. (U.S.)
- TERUMO Corporation (Japan)
- Koninklijke Philips N.V. (Netherlands)
- Fujifilm SonoSite (Japan), Hologic, Inc. (U.S.)
- Esaote SpA (Italy)
- Carestream Health, Inc. (U.S.)
- Konica Minolta (Japan)
- Alpinion Medical Systems (South Korea)
Highlights of The Peripheral Angiography Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Magnetic Resonance Imaging
- Computed Tomography
- Ultrasound
- Nuclear Imaging
- X-ray
- By Application:
- Hospitals
- Diagnostic Imaging Centres
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peripheral Angiography Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Peripheral angiography equipment is a medical imaging device that uses X-rays to create pictures of the blood vessels in the body. This type of imaging can be used to diagnose and treat conditions such as coronary artery disease, stroke, and peripheral vascular disease.
Some of the major companies in the peripheral angiography equipment market are Siemens Healthineers (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Samsung Medison (South Korea), Shimadzu Corp. (Japan), St. Jude Medical, Inc. (U.S.), TERUMO Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Fujifilm SonoSite (Japan), Hologic, Inc. (U.S.), Esaote SpA (Italy), Carestream Health, Inc. (U.S.), Konica Minolta (Japan), Alpinion Medical Systems (South Korea).
The peripheral angiography equipment market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Peripheral Angiography Equipment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Peripheral Angiography Equipment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Peripheral Angiography Equipment Market - Supply Chain
4.5. Global Peripheral Angiography Equipment Market Forecast
4.5.1. Peripheral Angiography Equipment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Peripheral Angiography Equipment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Peripheral Angiography Equipment Market Absolute $ Opportunity
5. Global Peripheral Angiography Equipment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Peripheral Angiography Equipment Market Size and Volume Forecast by Type
5.3.1. Magnetic Resonance Imaging
5.3.2. Computed Tomography
5.3.3. Ultrasound
5.3.4. Nuclear Imaging
5.3.5. X-ray
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Peripheral Angiography Equipment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Peripheral Angiography Equipment Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Diagnostic Imaging Centres
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Peripheral Angiography Equipment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Peripheral Angiography Equipment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Peripheral Angiography Equipment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Peripheral Angiography Equipment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Peripheral Angiography Equipment Demand Share Forecast, 2019-2026
9. North America Peripheral Angiography Equipment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Peripheral Angiography Equipment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Peripheral Angiography Equipment Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Diagnostic Imaging Centres
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Peripheral Angiography Equipment Market Size and Volume Forecast by Type
9.7.1. Magnetic Resonance Imaging
9.7.2. Computed Tomography
9.7.3. Ultrasound
9.7.4. Nuclear Imaging
9.7.5. X-ray
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Peripheral Angiography Equipment Demand Share Forecast, 2019-2026
10. Latin America Peripheral Angiography Equipment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Peripheral Angiography Equipment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Peripheral Angiography Equipment Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Diagnostic Imaging Centres
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Peripheral Angiography Equipment Market Size and Volume Forecast by Type
10.7.1. Magnetic Resonance Imaging
10.7.2. Computed Tomography
10.7.3. Ultrasound
10.7.4. Nuclear Imaging
10.7.5. X-ray
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Peripheral Angiography Equipment Demand Share Forecast, 2019-2026
11. Europe Peripheral Angiography Equipment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Peripheral Angiography Equipment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Peripheral Angiography Equipment Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Diagnostic Imaging Centres
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Peripheral Angiography Equipment Market Size and Volume Forecast by Type
11.7.1. Magnetic Resonance Imaging
11.7.2. Computed Tomography
11.7.3. Ultrasound
11.7.4. Nuclear Imaging
11.7.5. X-ray
11.8. Basis Point Share (BPS) Analysis by ype
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Peripheral Angiography Equipment Demand Share, 2019-2026
12. Asia Pacific Peripheral Angiography Equipment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Peripheral Angiography Equipment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Peripheral Angiography Equipment Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Diagnostic Imaging Centres
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Peripheral Angiography Equipment Market Size and Volume Forecast by Type
12.7.1. Magnetic Resonance Imaging
12.7.2. Computed Tomography
12.7.3. Ultrasound
12.7.4. Nuclear Imaging
12.7.5. X-ray
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Peripheral Angiography Equipment Demand Share, 2019-2026
13. Middle East & Africa Peripheral Angiography Equipment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Peripheral Angiography Equipment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Peripheral Angiography Equipment Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Diagnostic Imaging Centres
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Peripheral Angiography Equipment Market Size and Volume Forecast by Type
13.7.1. Magnetic Resonance Imaging
13.7.2. Computed Tomography
13.7.3. Ultrasound
13.7.4. Nuclear Imaging
13.7.5. X-ray
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Peripheral Angiography Equipment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Peripheral Angiography Equipment Market: Market Share Analysis
14.2. Peripheral Angiography Equipment Distributors and Customers
14.3. Peripheral Angiography Equipment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Siemens Healthineers (Germany)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GE Healthcare (U.K.)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Toshiba Medical Systems Corporation (Japan)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Hitachi Medical Corporation (Japan)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Samsung Medison (South Korea)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Shimadzu Corp. (Japan)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. St. Jude Medical, Inc. (U.S.)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. TERUMO Corporation (Japan)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Koninklijke Philips N.V. (Netherlands)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Fujifilm SonoSite (Japan), Hologic, Inc. (U.S.)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Esaote SpA (Italy)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Carestream Health, Inc. (U.S.)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Konica Minolta (Japan)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Alpinion Medical Systems (South Korea)
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
